Avicenna has announced the launch of its new Immunology diagnostics line called AviImmuneTM.
The first product of the line “AviImmune COV19 G/M/A ELISA” kits are intended for the qualitative detection of antibodies to SARS-CoV-2 virus in human serum. The assays are in ideal supplement for direct pathogen detection and are valuable tool for epidemiological studies. The ELISA kits demonstrate high sensitivity and specificity > 98%.
Avicenna’s Product Manager, Nisreen Haddadin, emphasized, “We believe that the launch of AviImmune COV19 Antibody detection ELISA kits will be the perfect complementary solution for the AviMol COV19 rtPCR diagnostics kits, and It will provide the customers with a high quality all-in-one solution for COVID-19 diagnosis and screening.”